{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:52:19Z","timestamp":1792093939793,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":134,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jchf.2026.103101","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:10:48Z","timestamp":1780337448000},"page":"103101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches"],"prefix":"10.1016","volume":"14","author":[{"given":"Shannon M.","family":"Dunlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Colvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Cowger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa G.","family":"Crespo Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-7786","authenticated-orcid":false,"given":"Onyedika J.","family":"Ilonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Lala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen K.","family":"McIlvennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0268-7817","authenticated-orcid":false,"given":"Sean P.","family":"Pinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren K.","family":"Truby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde W.","family":"Yancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne W.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2026.103101_bib1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamacardio.2021.4024","article-title":"Identifying treatments for stage C2 heart failure","volume":"7","author":"Yancy","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2024.5328","article-title":"Recognition of the large ambulatory C2D stage of advanced heart failure\u2014a call to action","volume":"10","author":"Dunlay","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ejhf.2561","article-title":"Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry","volume":"24","author":"Pagnesi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011003","article-title":"Detailed assessment of the \"I Need Help\" criteria in patients with heart failure: insights from the HELP-HF registry","volume":"16","author":"Pagnesi","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib8","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib9","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacc.2022.11.023","article-title":"Worsening heart failure: nomenclature, epidemiology, and future directions: JACC Review Topic of the Week","volume":"81","author":"Greene","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ejhf.2874","article-title":"Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology","volume":"25","author":"Metra","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.healun.2017.02.010","article-title":"\u201cI Need Help\u201d\u2014a mnemonic to aid timely referral in advanced heart failure","volume":"36","author":"Baumwol","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib15","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib18","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa2314328","article-title":"Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation","volume":"391","author":"Anker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.healun.2018.09.021","article-title":"Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) registry","volume":"38","author":"Ambardekar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jchf.2024.05.008","article-title":"Optimizing triage of ambulatory patients with advanced heart failure: 2-year outcomes from REVIVAL","volume":"12","author":"Aaronson","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ejhf.3523","article-title":"Discontinuation and reinitiation of mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction","volume":"27","author":"Landucci","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib23","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jchf.2023.04.017","article-title":"Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib24","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ejhf.3445","article-title":"Heart failure in Europe: guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction\u2014the ESC EORP Heart Failure III Registry","volume":"26","author":"Lund","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/eurjpc\/zwad151","article-title":"Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry","volume":"30","author":"Chioncel","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.15420\/cfr.2018.35.1","article-title":"Focusing on referral rather than selection for advanced heart failure therapies","volume":"5","author":"Thorvaldsen","year":"2019","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jchf.2026.103101_bib28","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1161\/CIR.0000000000001016","article-title":"Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association","volume":"144","author":"Morris","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.3112","article-title":"The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: data from the Swedish Heart Failure Registry","volume":"26","author":"Tomasoni","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103101_bib31","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jchf.2024.09.013","article-title":"Decongestion and outcomes in patients hospitalized for acute heart failure: insights from the RELAX-AHF-2 trial","volume":"13","author":"Pagnesi","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib32","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ejhf.1492","article-title":"Acute heart failure congestion and perfusion status\u2014impact of the clinical classification on in-hospital and long-term outcomes: insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/CIRCULATIONAHA.119.039920","article-title":"Prognostic implications of congestion on physical examination among contemporary patients with heart failure and reduced ejection fraction: PARADIGM-HF","volume":"140","author":"Selvaraj","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008789","article-title":"Reasons for guideline nonadherence at heart failure discharge","volume":"7","author":"Gilstrap","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103101_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory\u2014a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2024.05.030","article-title":"Early uptitration of GDMT is associated with more successful decongestion and better outcomes","volume":"84","author":"Bozkurt","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib37","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cardfail.2023.02.015","article-title":"Beyond stage C: considerations in the management of patients with heart failure progression and gaps in evidence","volume":"29","author":"Carroll","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2025.01.011","article-title":"Do potassium binders block both the benefits and the risks of mineralocorticoid receptor antagonists in heart failure? The four anti-aldosterone myths","volume":"85","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib39","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1093\/eurheartj\/ehac401","article-title":"Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103101_bib40","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/CIRCULATIONAHA.120.052503","article-title":"Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial","volume":"143","author":"Nassif","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib41","article-title":"Changes in seated pulmonary artery pressure in response to titration of heart failure medications during ambulatory monitoring","author":"Zalawadiya","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008212","article-title":"Early reduction in ambulatory pulmonary artery pressures after initiation of sacubitril\/valsartan","volume":"14","author":"Desai","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ejhf.3066","article-title":"Hypotension in heart failure is less harmful if associated with high or increasing doses of heart failure medication: insights from the Swedish Heart Failure Registry","volume":"26","author":"Girerd","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib44","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2024.06.002","article-title":"2024 ACC expert consensus decision pathway on clinical assessment, management, and trajectory of patients hospitalized with heart failure focused update: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"84","author":"Writing","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib45","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jacbts.2022.05.010","article-title":"Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions","volume":"8","author":"Bozkurt","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103101_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2021.4567","article-title":"Effect of treatment with sacubitril\/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"7","author":"Mann","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","article-title":"Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy","volume":"37","author":"Waagstein","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/j.jchf.2026.103101_bib49","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib50","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0735-1097(01)01516-9","article-title":"Metoprolol controlled release\/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study","volume":"38","author":"Goldstein","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib51","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib53","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/eurjhf\/hft010","article-title":"Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial","volume":"15","author":"Gheorghiade","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2362.2000.00627.x","article-title":"Effect of digoxin on circadian blood pressure values in patients with congestive heart failure","volume":"30","author":"Kirch","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchf.2026.103101_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102675","article-title":"Digoxin reduces pulmonary artery pressure in patients with heart failure: a report of the CardioMEMS database","volume":"13","author":"Lindenfeld","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib59","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2415471","article-title":"Digitoxin in patients with heart failure and reduced ejection fraction","volume":"393","author":"Bavendiek","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib60","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib62","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103101_bib64","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/ehf2.14455","article-title":"Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)","volume":"10","author":"Abdin","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib65","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1002\/ehf2.14050","article-title":"Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial","volume":"9","author":"Senni","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib66","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(25)01665-4","article-title":"Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial","volume":"406","author":"Butler","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103101_bib67","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0735-1097(24)02514-2","article-title":"Midodrine use and mortality in heart failure with reduced ejection fraction","volume":"83(suppl)","author":"Findlay","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib68","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103101_bib69","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamacardio.2021.4027","article-title":"Assessment of omecamtiv mecarbil for the treatment of patients with severe heart failure: a post hoc analysis of data from the GALACTIC-HF randomized clinical trial","volume":"7","author":"Felker","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib70","unstructured":"Study with omecamtiv mecarbil (CK-1827452) to treat chronic heart failure with severely reduced ejection fraction (COMET-HF). Accessed December 11, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06736574"},{"key":"10.1016\/j.jchf.2026.103101_bib71","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.jacc.2025.09.1511","article-title":"Danicamtiv, a selective agonist of cardiac myosin, for dilated cardiomyopathy: a phase 2 open-label trial","volume":"86","author":"Lakdawala","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib72","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/ejhf.3719","article-title":"Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure","volume":"27","author":"Tomasoni","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.106.629261","article-title":"Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure","volume":"115","author":"Lindenfeld","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103101_bib74","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jchf.2018.02.016","article-title":"Cardiac resynchronization therapy in inotrope-dependent heart failure patients: a systematic review and meta-analysis","volume":"6","author":"Hernandez","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib75","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ejhf.2929","article-title":"Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: an analysis from the ESC-HFA Heart Failure Long-Term Registry","volume":"25","author":"Adamo","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib76","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib77","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jacc.2023.11.012","article-title":"Transcatheter edge-to-edge repair in COAPT-ineligible patients with functional mitral regurgitation","volume":"83","author":"Chhatriwalla","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib78","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/ehf2.14273","article-title":"Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: results from the global EXPAND study","volume":"10","author":"Shuvy","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib79","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.healun.2020.09.005","article-title":"MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry","volume":"39","author":"Godino","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa2401918","article-title":"Transcatheter valve replacement in severe tricuspid regurgitation","volume":"392","author":"Hahn","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib81","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","article-title":"Transcatheter repair for patients with tricuspid regurgitation","volume":"388","author":"Sorajja","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103101_bib82","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2023.11.030","article-title":"Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction","volume":"83","author":"Lindenfeld","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib83","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","article-title":"Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial","volume":"401","author":"Brugts","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103101_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","article-title":"Baroreflex activation therapy in patients with heart failure with reduced ejection fraction","volume":"76","author":"Zile","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib85","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib86","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cardfail.2011.05.006","article-title":"Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure","volume":"17","author":"Abraham","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib88","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2023.08.025","article-title":"Donation After circulatory death: shifting the paradigm in heart transplantation","volume":"82","author":"Pinney","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib89","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1016\/j.ajt.2024.01.016","article-title":"OPTN\/SRTR 2022 annual data report: heart","volume":"24","author":"Colvin","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib90","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1016\/j.ajt.2025.01.024","article-title":"OPTN\/SRTR 2023 annual data report: heart","volume":"25","author":"Colvin","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.athoracsur.2023.11.004","article-title":"The Society of Thoracic Surgeons Intermacs 2023 annual report: focus on magnetically levitated devices","volume":"117","author":"Jorde","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jchf.2026.103101_bib92","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2026.103101_bib93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009179","article-title":"Relation of household income to access and adherence to combination sacubitril\/valsartan in heart failure: a retrospective analysis of commercially insured patients","volume":"15","author":"Johnson","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2026.103101_bib94","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008662","article-title":"Socioeconomic disparities in referral for invasive hemodynamic evaluation for advanced heart failure: a nationwide cohort study","volume":"14","author":"Larsson","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100966","article-title":"Advancing equitable cardiovascular care for patients with heart failure through innovation and multidisciplinary team-based care","volume":"3","author":"Ogunniyi","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jchf.2026.103101_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010133","article-title":"Mapping geographic proximity to cardiologists across the United States","volume":"16","author":"Motairek","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2026.103101_bib97","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamacardio.2018.0589","article-title":"Social worker-aided palliative care intervention in high-risk patients with heart failure (SWAP-HF): a pilot randomized clinical trial","volume":"3","author":"O'Donnell","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib98","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1053-2498(01)00298-4","article-title":"Preferences for quality of life or survival expressed by patients with heart failure","volume":"20","author":"Lewis","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103101_bib99","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.jacc.2008.08.028","article-title":"Changing preferences for survival after hospitalization with advanced heart failure","volume":"52","author":"Stevenson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103101_bib100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jchf.2024.01.010","article-title":"Palliative care across the spectrum of heart failure","volume":"12","author":"Gelfman","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103101_bib101","series-title":"Realizing the Promise of Equity in the Organ Transplantation System","year":"2022"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926002003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:43:20Z","timestamp":1792093400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213177926002003"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103101","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103101"}}